NCT00442611View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Scleroderma, DiffuseScleroderma, Systemic

Interventions

DRUG

Abatacept

DRUG

Placebo

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Stanford University

OTHER